Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering
Journal of Chemical Information and Modeling · 11.03.2024 · 64 (5) · 1615-1627
DOI: 10.1021/acs.jcim.3c01500 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 15.02.2024. Verfasst von Tien-Sheng Tseng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Molecular Biology, National Chung Hsing University, Taichung 40202, Taiwan. Hauptthemen laut MEDLINE: Neoplasms, Bacteriophages. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Cancer immunotherapy harnesses the immune system to combat tumors and has emerged as a major cancer treatment modality. The PD-1/PD-L1 immune checkpoint modulates interactions between tumor cells and T cells and has been extensively targeted in cancer immunotherapy. However, the monoclonal antibodies known to target this immune checkpoint have considerable side effects, and novel PD-1/PD-L1 inhibitors are therefore required. Herein, a peptide inhibitor to disrupt PD-1/PD-L1 interactions was designed through structure-driven phage display engineering coupled to computational modification and optimization. BetaPb, a novel peptide library constructed by using the known structure of PD-1/PD-L, was used to develop inhibitors against the immune checkpoint, and specific peptides with high affinity toward PD-1 were screened through enzyme-linked immunosorbent assays, homogeneous time-resolved fluorescence, and biolayer interferometry. A potential inhibitor, B8, was preliminarily screened through biopanning. The binding affinity of B8 toward PD-1 was confirmed through computation-aided optimization. Assessment of B8 variants (B8.1, B8.2, B8.3, B8.4, and B8.5) demonstrated their attenuation of PD-1/PD-L1 interactions. B8.4 exhibited the strongest attenuation efficiency at a half-maximal effective concentration of 0.1 μM and the strongest binding affinity to PD-1 (equilibrium dissociation constant = 0.1 μM). B8.4 outperformed the known PD-1/PD-L1 interaction inhibitor PL120131 in disrupting PD-1/PD-L1 interactions, revealing that B8.4 has remarkable potential for modification to yield an antitumor agent. This study provides valuable information for the future development of peptide-based drugs, therapeutics, and immunotherapies for cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Institute of Molecular Biology, National Chung Hsing University, Taichung 40202, Taiwan.
- National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei 11221, Taiwan.
- The School of Chinese Medicine for Post Baccalaureate, I-Shou University, Kaohsiung 824005, Taiwan.
- Department of Chinese Medicine, E-Da Hospital, Kaohsiung 824005, Taiwan.
- TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan.
- Ph.D. Program in Medical Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan.
ORCID-Profile: Keng-Chang Tsai
Förderung
- National Science and Technology Council
Zitieren
APA
Tseng, T. S., Lee, C. C., Chen, P. J., Lin, C. Y., Chen, W. C., Lee, Y. C., Lin, J. H., Chen, K. W., & Tsai, K. C. (2024). Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering. Journal of Chemical Information and Modeling, 64(5), 1615-1627. https://doi.org/10.1021/acs.jcim.3c01500
Vancouver
Tseng TS, Lee CC, Chen PJ, Lin CY, Chen WC, Lee YC, et al. Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering. Journal of Chemical Information and Modeling. 2024;64(5):1615-1627. doi:10.1021/acs.jcim.3c01500
BibTeX
@article{Tseng2024,
author = {Tseng, Tien-Sheng and Lee, Chao-Chang and Chen, Po-Juei and Lin, Chiu-Yuen and Chen, Wang-Chuan and Lee, Yu-Ching and Lin, Jiun-Han and Chen, Kaun-Wen and Tsai, Keng-Chang},
title = {Structure-Guided Discovery of PD-1/PD-L1 Interaction Inhibitors: Peptide Design, Screening, and Optimization via Computation-Aided Phage Display Engineering},
journal = {Journal of Chemical Information and Modeling},
year = {2024},
volume = {64},
number = {5},
pages = {1615--1627},
doi = {10.1021/acs.jcim.3c01500}
}
EUVIMED